These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12422540)

  • 1. [Cutaneous side-effects in drug assessment].
    Jean-Pastor MJ
    Therapie; 2002; 57(3):265-8. PubMed ID: 12422540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug-eruptions].
    Thielen AM; Toutous-Trellu L; Desmeules J
    Rev Med Suisse; 2008 Jul; 4(165):1671-5. PubMed ID: 18767294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous reactions to topical medications].
    Barbaud A
    Rev Prat; 2000 Jun; 50(12):1324-8. PubMed ID: 10972074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval.
    Borer JS; Pouleur H; Abadie E; Follath F; Wittes J; Pfeffer MA; Pitt B; Zannad F
    Eur Heart J; 2007 Aug; 28(15):1904-9. PubMed ID: 17615083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulatory guidelines and drug safety].
    Flury W
    Ther Umsch; 1993 Jan; 50(1):49-51. PubMed ID: 8378867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmaco-surveillance of drug-induced cutaneous accidents].
    Barbaud A; Tréchot P; Schmutz JL
    Ann Dermatol Venereol; 1997; 124(6-7):474-5. PubMed ID: 9739914
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug patch tests in the investigation of cutaneous adverse drug reactions].
    Barbaud A
    Ann Dermatol Venereol; 2009; 136(8-9):635-44. PubMed ID: 19686903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug surveillance and topical drugs].
    Roujeau JC
    Ann Dermatol Venereol; 1996; 123(10):624-5. PubMed ID: 9615120
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe cutaneous adverse reactions.
    Grover S
    Indian J Dermatol Venereol Leprol; 2011; 77(1):3-6. PubMed ID: 21220872
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-induced cutaneous pathology.
    Ramdial PK; Naidoo DK
    J Clin Pathol; 2009 Jun; 62(6):493-504. PubMed ID: 19155238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of drug side effects at the Heidelberg Medical Clinic].
    Jacubeit T; Drisch D
    Verh Dtsch Ges Inn Med; 1989; 95():690-3. PubMed ID: 2603505
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiologic assessment of adverse drug effects.
    Stern RS
    Semin Dermatol; 1989 Sep; 8(3):136-40. PubMed ID: 2701270
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mandatory report of adverse effects of drugs: has the order modified the spontaneous notification?].
    Haramburu F; Pere JC; Begaud B; Albin H
    Therapie; 1988; 43(6):493-6. PubMed ID: 3227516
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug-induced cutaneous photosensitivity. Results of a consensus meeting].
    Roujeau JC; Beani JC; Dubertret L; Guillaume JC; Jeanmougin M; Danan G; Lagier G; Benichou C
    Therapie; 1989; 44(3):223-7. PubMed ID: 2528839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comprehensive detection of severe, potentially life-threatening drug side effects].
    Schönhöfer PS; Wessely-Stickel B; Schulte-Sasse H; Werner W
    Verh Dtsch Ges Inn Med; 1989; 95():687-90. PubMed ID: 2603504
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cost/benefit analysis of a regional drug surveillance center].
    Mignot G; Chichmanian RM; Spreux A; Bernard G
    Therapie; 1988; 43(5):377-8. PubMed ID: 3147546
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness of skin testing in cutaneous drug eruptions in routine practice.
    Tchen T; Reguiaï Z; Vitry F; Arnoult E; Grange A; Florent G; Bernard P
    Contact Dermatitis; 2009 Sep; 61(3):138-44. PubMed ID: 19780771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous reactions to drugs].
    Mulder WM; Meinardi MM; Bruynzeel DP
    Ned Tijdschr Geneeskd; 2004 Feb; 148(9):415-20. PubMed ID: 15038200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An underrecognized challenge in evaluating postmarketing drug safety.
    Roden DM
    Circulation; 2005 Jan; 111(3):246-8. PubMed ID: 15668350
    [No Abstract]   [Full Text] [Related]  

  • 20. Importance of valid measurements of benefit and risk.
    Spitzer WO
    Med Toxicol; 1986; 1 Suppl 1():74-8. PubMed ID: 3821430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.